AI Innovation in Healthcare: Wolters Kluwer Introduces UpToDate®-Powered AI Labs

AI Innovation in Healthcare: Wolters Kluwer Introduces UpToDate®-Powered AI Labs

(IN BRIEF) Wolters Kluwer Health introduces AI Labs, a Clinical Generative AI (GenAI) initiative powered by UpToDate®, its trusted clinical decision support solution. AI Labs gains access to UpToDate’s comprehensive clinical content and is made available to over 100 U.S. hospitals and major health systems. The initiative aims to provide evidence-based answers quickly and efficiently to care teams, leveraging natural language queries and customer feedback to continually improve. Wolters Kluwer Health’s commitment to transparency and collaboration has earned recognition as a healthcare technology pioneer. AI Labs will be showcased at the HIMSS24 Global Conference and Exhibition.

(PRESS RELEASE) ALPHEN AAN DEN RIJN, Netherlands, 11-Mar-2024 — /EuropaWire/ — Wolters Kluwer Health, a Wolters Kluwer N.V. (AMS: WKL) subsidiary, is pleased to announce significant milestones for AI Labs, the Clinical Generative AI (GenAI) beta initiative launched in 2023 and driven by UpToDate®, the globally respected clinical decision support (CDS) solution. AI Labs now boasts access to UpToDate’s comprehensive library of evidence-based clinical content and graded recommendations across over 25 medical specialties, making it the only large language model (LLM) exclusively powered by UpToDate’s trusted resources.

With the introduction of UpToDate Enterprise™ Edition, over 100 U.S. hospitals and major health systems gain access to AI Labs’ testing and validation program. This program marks a crucial phase in the development of Clinical GenAI as a dependable and reputable point-of-care solution.

A Foundation of Trust in Clinical GenAI In a recent Wolters Kluwer survey, Americans expressed concern over the source and validation of medical information used in GenAI healthcare applications. Building Clinical GenAI tools that care teams rely on for clear, evidence-based answers requires a focus on safety, reliability, and trust through transparency.

Setting the Standard for Clinical GenAI Greg Samios, President & CEO of Clinical Effectiveness at Wolters Kluwer Health, emphasizes the company’s commitment to creating an interactive and transformative experience for clinicians and care teams, stating “Building Clinical GenAI tools that care teams turn to for clear, evidence-based answers is more than a technology challenge—it’s a responsibility to focus on safety, reliability, and trust through transparency.

Continual Innovation in Clinical GenAI UpToDate’s AI Lab has developed core capabilities ranging from direct retrieval of UpToDate content to AI-synthesized responses based solely on UpToDate’s unparalleled resources. By leveraging natural language queries, AI Labs provides targeted answers drawn exclusively from UpToDate’s regularly updated content, ensuring relevance and accuracy.

Customer Collaboration for Enhanced GenAI Customers play a crucial role in AI Labs’ ongoing development.

Discussing the potential of GenAI for healthcare, Eric Alper, MD, Senior Vice President, Chief Quality Officer, and Chief Clinical Informatics Officer at UMass Memorial Health stated: “UpToDate has long provided clinicians with the information they need to make clinical decisions. From what I’ve seen, the combination of UpToDate with GenAI through AI Labs could get clinicians to expert, succinct, evidenced-based content even faster.”

Customers play a valuable role in the ongoing development of AI Labs. Julio Ramirez, MD, Chief Scientific Officer at Norton Infectious Diseases Institute commented, “I’ve provided feedback to Wolters Kluwer on AI Labs since last year. I’m impressed with their approach and the progress they have made on the responsible use of Gen AI in clinical decision support. With the entire UpToDate content set now in AI Labs, as well as expanded access to the testing and validation program by more clinicians, there is the opportunity to accelerate the use of Gen AI in clinical decision support.”

Patrick Snowman, MD, Chief, Department of Medicine at Hilton Head Regional Health explains: “In the Emergency Department, time is of the essence.  It is imperative to have a solution like UpToDate to quickly access vital information that supports clinical care. I look forward to testing and validating that GenAI, when combined with UpToDate, offers the ability to get faster and more concise answers in support of delivering better care.”

Recognition as a Healthcare Technology Pioneer Wolters Kluwer Health has been honored as a healthcare technology pioneer for GenAI in clinical settings by industry analysts at Frost & Sullivan, affirming the company’s innovative approach.

Experience AI Labs at HIMSS24 AI Labs will be showcased at the Wolters Kluwer booth, #2927, at the HIMSS24 Global Conference and Exhibition. Learn more about Wolters Kluwer’s mission for Clinical GenAI by watching the provided video.

About Wolters Kluwer

Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services.

Media contact:

Andre Rebelo
Director, External Communications
Health
andre.rebelo@wolterskluwer.com
+1 (781) 392-2411

SOURCE: Wolters Kluwer N.V.